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ABSTRACT
Introduction The COVID-19 pandemic has required the 
rapid development of comprehensive guidelines to direct 
health service organisation and delivery. However, most 
guidelines are based on resources found in high- income 
settings, with fewer examples that can be implemented 
in resource- constrained settings. This study describes 
the process of adapting and developing role- specific 
guidelines for comprehensive COVID-19 infection 
prevention and control in low- income and middle- income 
countries (LMICs).
Methods We used a collaborative autoethnographic 
approach to explore the process of developing COVID-19 
guidelines. In this approach, multiple researchers 
contributed their reflections, conducted joint analysis 
through dialogue, reflection and with consideration of 
experiential knowledge and multidisciplinary perspectives 
to identify and synthesise enablers, challenges and key 
lessons learnt.
Results We describe the guideline development 
process in the Philippines and the adaptation process 
in Sri Lanka. We offer key enablers identified through 
this work, including flexible leadership that aimed to 
empower the team to bring their expertise to the process; 
shared responsibility through equitable ownership; 
an interdisciplinary team; and collaboration with local 
experts. We then elaborate on challenges including 
interpreting other guidelines to the country context; 
tensions between the ideal compared with the feasible 
and user- friendly; adapting and updating with evolving 
information; and coping with pandemic- related challenges. 
Based on key lessons learnt, we synthesise a novel set 
of principles for developing guidelines during a public 
health emergency. The SPRINT principles are grounded in 
situational awareness, prioritisation and balance, which are 
responsive to change, created by an interdisciplinary team 
navigating shared responsibility and transparency.
Conclusions Guideline development during a pandemic 
requires a robust and time sensitive paradigm. We 
summarise the learning in the ‘SPRINT principles’ for 
adapting guidelines in an epidemic context in LMICs. We 
emphasise that these principles must be grounded in a 
collaborative or codesign process and add value to existing 
national responses.
INTRODUCTION
The COVID-19 pandemic has required the 
rapid development of comprehensive guide-
lines to direct health service organisation and 
health delivery. Beginning with initial docu-
ments based on clinical experience in Wuhan, 
China, guidance for the prevention, diagnosis 
and management of COVID-19 have prolifer-
ated globally. In particular, infection preven-
tion and control (IPC) guidelines offer clear 
directions on the arrangement and delivery 
Key questions
What is already known?
 ► Infection prevention and control (IPC) guidelines to 
safely provide high- quality care for COVID-19 have 
been rapidly created.
 ► These guidelines are often not role specific and diffi-
cult to implement in low- resource settings.
What are the new findings?
 ► Codesign between interdisciplinary team members 
is an important tool towards rapidly developing IPC 
guidelines for low- resource settings during public 
health emergencies.
 ► We propose the following ‘SPRINT’ principles to 
guide teams in cocreating IPC guidelines in response 
to public health emergencies: situational awareness; 
prioritisation and balance; responsive and reflective; 
interdisciplinary teams; navigating shared responsi-
bility; and transparency.
What do the new findings imply?
 ► The ideal guidelines during a public health emer-
gency are those that are contextually relevant, based 
on best available evidence, and quickly reach health 
workers to ensure the provision of safe and high- 
quality care.
 ► Creating such guidelines requires flexible approach-
es and an interdisciplinary team with both contextual 
and clinical knowledge.
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of health services to enable health workers to consistently 
provide high- quality care.1 These guidelines are critical 
during infectious disease outbreaks to ensure appro-
priate triage and care of patients, reduce transmission 
among health workers, and prevent nosocomial spread 
in healthcare facilities.2 In the case of novel infectious 
diseases, guidance must be rapidly developed based on 
emerging evidence on disease transmission characteris-
tics including routes of transmission and infectivity.3
While there are numerous IPC guidelines from various 
authorities including the World Health Organization 
(WHO), there are fewer context and role- specific guide-
lines with complementary training materials. Many 
existing guidelines are based on resources found in high- 
income settings, and from settings in China. There are 
fewer examples of guidelines that can be adapted and 
implemented in more resource- constrained settings.4 
This is particularly concerning given the dispropor-
tionate and growing burden of COVID-19 in low- income 
and middle- income countries (LMICs) and the resource 
constraints facing their health systems.5 Further, these 
guidelines will continue to be cornerstones of COVID-19 
prevention and mitigation for the foreseeable future in 
these settings due to ongoing global inequities in vaccine 
delivery.6
This study aims to explore the process of rapidly devel-
oping IPC guidance and training materials in a pandemic 
situation. Specifically, we describe the process of adapting 
and developing role- specific guidelines for comprehen-
sive IPC practices for COVID-19 pandemic management 
in LMICs.
Research setting
This work was a part of a larger study, which aimed to 
adapt, develop, and evaluate role- specific guidelines in 
the Philippines and modify them for Sri Lanka, with a goal 
to produce a generic version of the guidelines for further 
adaptation in other LMICs. Guidelines and associated 
training videos may be viewed at https://gisldlsphuto-
rontoca/projects-on-covid-19/. Given the rapid time-
line, sites were chosen based on existing partnerships. 
Figure 1 provides the geographical location and descrip-
tion of both countries. Additionally, we believed that 
understanding the process of development and adaption 
of COVID-19 guidelines in two different contexts would 
enable us to synthesise a breadth of lessons on guideline 
development during a public health emergency. Figure 2 
provides an overview of daily reported COVID-19 cases in 
each country and our timelines during the IPC guideline 
development process.
The Philippines
The Philippines recorded its first case of COVID-19 
on 7 March 2020 in Cebu province. By 24 April 2020, 
there were 8212 reported cases, rising to 18 997 cases in 
on 2 June 2020.7 8 As of 24 May 2021, there were over 
1.1 million cases and nearly 20 000 deaths reported across 
all 81 provinces.9 COVID-19 response measures in the 
Philippines have focused on border controls, enhanced 
community quarantine to restrict population mobility, 
and strategies to bolster the health system such as hiring 
new health workers and creating isolation facilities.10 
However, aspects of the initial response were problem-
atic. For example, some of the first available testing kits 
required overseas processing, which contributed to ineq-
uitable access and public hesitancy around COVID-19 
testing.11 Additionally, while the Department of Health 
(DOH) released guidelines early in the pandemic in the 
form of brief updates or ‘circulars’, these were high level 
and generalised.12 Preliminary interviews as part of our 
work have indicated that there were gaps in guidance, 
Figure 1 Geography, gross domestic product (GDP), population, and health system context for the Philippines and Sri Lanka.
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and health workers shared national and other ad hoc 
guidance through personal channels.
The guidelines development team in the Philippines, 
including coauthors (LLL and MC), was based at Inter-
national Care Ministries (ICM). ICM is a Philippine- 
based non- governmental organisation (NGO) that 
operates programmes in the Philippines, Uganda and 
Guatemala. The primary focus of the organisation is 
the implementation of a community- based poverty 
reduction programme, which provides education and 
interventions targeted at health and livelihoods. In the 
Philippines, ICM has approximately 500 full- time staff, 
and over 250 000 households have participated in ICM 
programmes. During the strict restrictions on move-
ment enforced during the COVID-19 peaks, ICM health 
programmes shifted towards addressing acute food secu-
rity needs and infection prevention education.
In the Philippines, we aimed to develop IPC guidelines 
for health workers in the following settings: (1) health 
workers providing care in inpatient healthcare settings, 
namely public and private hospitals; (2) health workers 
providing care in outpatient healthcare settings, namely 
outpatient departments in public and private hospitals; 
(3) health workers providing care in primary healthcare 
settings including rural health units and (4) community 
health workers in community sites, including barangay 
health stations.
Sri Lanka
Sri Lanka reported its first case of COVID-19 on 27 
January 2020, and the individual was admitted to the 
National Institute of Infectious Diseases. Guidelines for 
COVID-19 management were established by the Ministry 
of Health (MOH) in January 2020. The initial COVID-19 
response in Sri Lanka took an aggressive containment 
approach with strict border controls and the establish-
ment of quarantine centres for returning travellers. All 
confirmed cases were hospitalised. Sri Lanka leveraged 
on its pre- existing and robust public health infrastructure 
and workforce to mobilise comprehensive testing and 
contact tracing protocols to break chains of transmission 
in communities.13 After initial success containing the first 
wave, Sri Lanka started reopening the country and the 
second wave started in October 2020 with decreasing 
cases loads until April 2021. However, following the 
Sinhala and Tamil New Year in mid- April, a rapid surge 
in case incidence and spread of COVID-19 beyond the 
Western province has increasingly strained resources. 
By 24 May 2021, there were 164 000 reported cases of 
COVID-19 and 1210 deaths. Although Sri Lanka had 
regularly updated comprehensive guidance in place at 
the outset of the project, our existing partners were inter-
ested in the feasibility of adapting guidelines and saw 
value in having training material for role- specific guide-
lines education for healthcare workers.
The guidelines development team in Sri Lanka 
included stakeholders from the MOH Sri Lanka with 
extensive clinical and public health experience (SS, NP) 
and a researcher in Canada (SR) who completed medical 
school in Sri Lanka and maintains close connections with 
Sri Lanka. Partner sites included a district hospital and 
two MOH areas. In Sri Lanka, we aimed to develop IPC 
guidelines for health workers in the following settings: 
(1) health workers providing care in inpatient settings, 
namely public hospitals; (2) health workers providing 
primary care; (3) health workers providing care in outpa-
tient settings, namely in outpatient departments of public 
hospitals and (4) field health workers providing commu-
nity care.
Figure 2 Timeline of activities and daily reported COVID-19 cases per million in the Philippines (PL) and Sri Lanka (SL).
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METHODS
This is a collaborative autoethnographic study where 
authors used their own experiences to expand our 
understanding of adapting and developing role- specific 
guidelines for comprehensive care of an emerging 
infectious disease in LMICs. Autoethnography uses a 
researcher’s experiences as primary data to analyse and 
interpret sociocultural meanings of events.14 Collabo-
rative autoethnographic research is a method whereby 
multiple researchers contribute their reflections on an 
event or experience, conduct joint analysis of the mate-
rial through dialogue, reflection and with consideration 
of experiential knowledge and multidisciplinary perspec-
tives.15 Team members actively involved in the adaptation 
and development of these guidelines in Canada, the Phil-
ippines, and Sri Lanka were invited to participate in a 
1- hour interview to explore their perceptions and expe-
riences with developing the guidelines, or provide a free 
form written response to the prompt ‘please describe the 
guideline development process from your perspective 
in your own words—including any specific examples of 
challenges or strengths of the development process.’
Participants were recruited in January 2021 after 
completion of IPC guideline development in both coun-
tries following several rounds of iteration. Nine team 
members participated in interviews, and two provided 
lengthy written replies. We provide a schematic of the 
team and their roles in online supplemental file 1. Team 
members were invited to participate as coauthors and were 
provided written details on the study including details 
on confidentiality of responses. Interviews were held via 
videoconference and team members were explained the 
study at the start of the interview and provided additional 
verbal consent. Interviews were conducted by a team 
member in Canada (VH), a PhD candidate who is expe-
rienced in qualitative methods and acted as study coor-
dinator between both teams since February 2020, thus 
establishing deep rapport with team members. Accounts 
were transcribed in full and anonymised. Based on these 
transcripts VH curated an ‘overarching narrative’ of the 
development process. The lens that VH brought to data 
collection and curation, meaning the condensation, cate-
gorisation, and creation of a cohesive master narrative 
from the interviews, was reviewed through a critical lens 
both by VH and SR in a process of active discussion during 
the curation process. This critical discussion included 
reflexive discussion around positionality on the team and 
in writing this manuscript (online supplemental file 2). 
Part of this reflection was considering the foreign gaze 
and to what extent a collaborative autoethnographic 
approach and our presentation of the autoethnography 
perpetuates or addresses what can be called ‘epistemic 
injustices’ in global health research and writing.16 17 This 
curated narrative was reviewed by all team members who 
provided candid and nuanced feedback during several 
videoconference meetings, numerous text messages, and 
written feedback on drafts to ensure coherence in light of 
multiple voices, perspectives and lived experiences.
Once the document reflected a shared perception of 
the overall process, three team members, (VH, SR and 
NP) developed themes on barriers and enablers based 
on transcripts, written data and the overarching narra-
tive.18 This process involved multiple discussions and 
reflection on the text by the three researchers to identify 
themes that captured barriers and enablers. The resul-
tant themes were then disseminated to all authors who 
confirmed and expanded on them through multiple 
emails and shared drafts. This process involved negotia-
tion between the team on how to articulate the narrative 
and principles, without silencing any voices or mini-
mising any experiences. We then synthesised our collec-
tive lessons learnt into key principles. This process also 
involved negotiation and reflection among the research 
team through multiple meetings to identify and refine 
the principles.
Patients or the public were not involved in the design, 
or conduct, or reporting, or dissemination plans of our 
research.
RESULTS
We organise our results by first offering a narrative of 
the steps in developing our context- specific and role- 
specific guidelines and training materials beginning 
with ‘the process’, that is (1) developing a baseline set of 
guidelines; (2) adapting these to the Philippines context 
and (3) again adapting to the Sri Lanka context. We 
then reflect on our experiences and offer barriers and 
enablers to guidelines development.
Sources and adaptation of guidelines
In early 2020, there were few clinical guidelines for the 
diagnosis, treatment and management of patients with 
COVID-19. As a foundation for our initial draft guide-
lines, in February 2020, we drew on guidelines from the 
WHO and China’s national COVID-19 response. We 
translated the guidelines from China and aimed to adapt 
them to the health system context of the Philippines and 
then, based on learnings from this adaption process, 
again adapt them to the health system context of Sri 
Lanka. To do so, we partnered with colleagues from both 
countries to develop role- specific guidelines and comple-
mentary training materials for health workers in each 
country. Our multinational teams organised into a Phil-
ippines Working Group and Sri Lanka Working Group 
jointly connected by a mutual team based in Canada with 
clinical expertise from the UK to support with guidance 
design, formatting and reviewing. A shared coordinator 
connected both working groups .
The team created preliminary drafts of the guide-
lines and their associated ‘desk guides.’ Desk guides 
are a condensed and easily accessible clinical tool to 
provide guidance to front- line healthcare workers based 
on experience from other disease control (http:// 
comdis- hsd. leeds. ac). To better understand emerging 
guidelines issued by WHO and national bodies globally, 
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we conducted a grey literature review.19 Some team 
members wondered if we should have a thorough search 
of the academic literature to build our awareness and 
understanding of the breadth of emerging guidelines, 
particularly as the virus spread globally and China ceased 
to be the sole epicentre and knowledge hub. One team 
member mentioned that ‘whatever recommendation we 
give, the evidence should be clear.’ However, there was 
tension between wanting definitive evidence and the 
often- changing guidance as scientists learnt more about 
the virus and disease characteristics. Given the prolifera-
tion of SARS- CoV-2 studies, we performed a comprehen-
sive literature search with a librarian, which yielded 3226 
references, many of them preprints. Finding and dissem-
inating the literature so that team members could update 
the guidelines with emerging evidence from research 
and practice quickly became an overwhelming task, as 
one team member commented ‘it was like trying to drink 
water from a fire hydrant.’ To cope with this, we began 
to structure literature check- ins, at first every 2 weeks, 
however, once there was fewer emergent COVID- specific 
IPC evidence, we reviewed the literature every 2 months. 
Additionally, research team members set up keyword- 
specific alerts and followed WHO briefings. Clinical team 
members kept abreast of any updates at their institutions 
or through their professional associations that may be 
useful for the study.
Developing guidelines for the Philippines
Here, we outline the process of developing guide-
lines for health workers in four unique health delivery 
settings in the Philippines: (1) Management Guidelines 
for COVID-19 Infection Prevention and Control in the 
Healthcare Setting; (2) Outpatient Consultation Desk 
Guide; (3) Primary Care Health Worker Desk Guide and 
(4) Barangay (Community) Health Worker Desk Guide.
Given the rising case numbers at the start of the project 
in March 2020, there was a sense of urgency in creating 
the guidelines. Furthermore, in the Philippines, the 
health system is fragmented with structural challenges 
to information dissemination among health facilities, 
namely underdeveloped information technology systems 
to ensure consistent information reaches all health facil-
ities, as well as information asymmetries between private 
and public providers, as well as geographical disparities in 
available resources.20 Importantly, our partner NGO had 
an immediate need for guidelines and training to protect 
their front- line staff in communities. These factors neces-
sitate a rapid and flexible approach to create and deliver 
usable and context- specific guidelines. To adapt available 
guidelines to the Philippines context, the team in the Phil-
ippines with support from the team in Toronto reviewed 
the preliminary guidelines draft, cross checked with the 
translated guidelines from China, the WHO guidelines, 
and locally available Philippines DOH guidelines. An 
important part of this process was then further adapting 
the guidelines based on the needs of additional groups 
of health workers identified by our partner organisation. 
For example, we adapted the guidelines and training 
materials for tuberculosis treatment partners (kagabays) 
who provide care in the community.
These documents were discussed at length over emails 
and through videoconference meetings with clinical 
consultation from staff affiliated with our partner organ-
isation in the Philippines and the Canada team. For 
example, some members of the team worked in teaching 
hospitals in Toronto and were aware of issues with and 
adherence to the initial Canadian guidelines, thus they 
posed questions about how the guidelines could feasibly 
be implemented in low- resource settings. Teams in both 
locations reviewed the emerging scientific literature, 
highlighted questions, and met regularly over videocon-
ference to resolve these uncertainties. Meetings focused 
on discussion considering both the evolving evidence 
on the nature and management of COVID-19, as well as 
the contextual differences between China and the Phil-
ippines. These meetings required the team to strike a 
balance between the objectives of the project, the COVID-
19- related IPC materials available, and the situation in 
the Philippines. This was achieved through an explicit 
awareness of our evolving understanding of the project, 
and negotiation of how to proceed despite uncertainty 
and challenges. This process challenged hierarchies and 
required a negotiation of power away from traditional 
research seniorities and roles and towards being reflexive 
to the needs of those in the field and indeed what was 
even possible in the research setting. Once the guide-
lines content was reviewed, another member of the team 
took the lead to make the guidelines concise and user 
friendly. The member responsible for copy editing and 
formatting also strived to check the accuracy of the latest 
version to ensure it was updated with key guidance from 
the WHO, US Centers for Disease Control and Preven-
tion (CDC) or national guidelines. We also implemented 
a final check- up process based on a review against most 
recent national guidelines and final read through by a 
healthcare worker affiliated with ICM to see if the guide-
lines fit into the resources available and requirements in 
the Philippines.
Concurrently, we developed training materials. 
However, due to ‘lock- down’ restrictions on move-
ment, we were unable to provide in- person training at 
many sites, and thus created materials to support virtual 
sessions. As such, ICM staff engaged with a film crew and 
celebrity to direct, film, and produce a series of training 
videos. A popular singer, who is also a registered nurse, 
played a major role in introducing and promoting the 
training videos which garnered credibility and held the 
attention of viewers in the Philippines. The production 
of these videos occurred during strict public health 
measures in the area. These circumstances required the 
Philippines team to be creative and flexible to complete 
filming, while still abiding by all public health measures, 
and ensuring the safety of themselves and others. The 
outcome of these efforts was a comprehensive suite of 
COVID-19 guidelines training materials and videos.2 
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These videos offered training and in- depth information 
on each chapter of the guidelines. Each video chapter 
included informational slides describing the guide-
lines, expert narration on the guidelines, and role play 
scenarios to illustrate the guidelines.
Adapting the guidelines for Sri Lanka
Here, we outline the process of developing guidelines 
for health workers in four unique health settings in Sri 
Lanka: (1) Management guidelines for COVID-19 infec-
tion prevention and control in the healthcare setting; (2) 
Primary care health worker desk guide in the context of 
COVID-19; (3) Desk guide for Outpatient Consultation 
in Hospital in the Context of COVID-19 and (4) Desk 
guide for Field Health Workers in the Context of COVID-
19.
The desk guides prepared by the Philippines team were 
shared with the Sri Lanka team in March 2020. During 
that time, the situation in Sri Lanka was fairly controlled 
with few cases and deaths. The ‘Provisional Clinical Prac-
tice Guidelines on COVID-19 suspected and confirmed 
patients’ and a ‘Manual for hospital preparedness for 
COVID-19’ were released and updated by the MOH in Sri 
Lanka. Our work intended to complement and enhance 
these materials.
In mid-2020, we submitted for ethics approval from 
the MOH and strengthened relationships with local 
partners. We anticipated bureaucratic delays when the 
pandemic situation worsened while seeking approvals. To 
better understand what elements would be most useful 
we conducted a needs assessment among health system 
stakeholders (results forthcoming). From this needs 
assessment our site partners highlighted that we needed 
to include guidelines and materials specifically for ancil-
lary staff, such as sanitation workers in hospital settings. 
The initial draft adapting the Philippines guidelines to 
the Sri Lanka context, which had been drafted in April 
2020, was of limited use given the evolving evidence and 
rapidly changing situation in Sri Lanka. Thus, we begin 
to again update the guidelines. This process involved six 
rounds of updating between team members in Canada 
and Sri Lanka to ensure accuracy, and then further review 
and formatting. By this time, in Sri Lanka, the second 
wave of infections had begun and there was increasing 
urgency and need for training material. This final review 
and editing process was an intense process that involved 
multiple telephone calls and videoconferences and took 
two weeks to complete.
By the end of November 2020, we had edited the guide-
lines to reflect new information and aligned with the 
latest high- level guidelines from Sri Lanka. At this time, 
the epidemic in Sri Lanka became overwhelming, and 
the review process became very hard for the team in Sri 
Lanka. Fortunately, we had good communication links 
with the partner sites and were able to pilot the guideline 
and training sessions. But it was tough, as a team member 
stated, ‘Honestly, if we did not know them personally, 
they would have had no reason to work on this at 9 pm 
after they finish their 14- hour work- day.’
Finally, stakeholder interviews were conducted in 
December 2020 and January 2021 to adapt the guides and 
identify specific needs for the training videos. We realised 
even at the late stage of preparing the videos that some of 
the technical information changed with emerging infor-
mation and had to put in a disclaimer stating that in any 
pandemic situation IPC guidelines continue to be modi-
fied with newly emerging evidence; however, basic IPC 
principles remain the same.
Team reflections: enablers and challenges to guidelines 
development
Based on our experiences, we summarise key enablers 
and challenges to the development of context- informed 
and role- specific guidelines for the treatment and 
management of COVID-19. We present these as themes 
created from our autoethnographic process (table 1).
A key enabler described was flexible leadership that 
aimed to empower the team to bring their expertise to 
the process. While this approach sometimes caused team 
members to feel like roles and responsibilities were not 
well- defined, it also challenged team members to seek 
broad sources of evidence and offer creative solutions to 
improve the guidelines. For example, one team member 
leveraged on her clinical and design skills to lead on 
making the guidelines user- friendly. This enabler closely 
related to the sense of shared responsibility and equitable 
ownership the process engendered. Researchers used 
their professionalism and expertise to take ownership 
of the guidelines each time it came to them for review 
and improvement. Finally, the interdisciplinary team 
brought multiple perspectives and experiences to the 
guidelines creation process. This included both profes-
sional experiences, as well as lived experience given that 
many team members were trained, previously practised 
or actively live and work in LMICs. In addition, the team 
worked closely and sought clinical guidance from front- 
line staff in both settings. Given that front- line staff were 
responding to the pandemic and had limited capacity to 
work on guideline development, this was a delicate task. 
As such, the guidelines development team relied on pre- 
existing relationships, sometimes informal ones, to find 
out specifics. Getting timely feedback was at times chal-
lenging, particularly when trying to make new connec-
tions, which sometimes felt like overstepping or imposing 
on busy front- line staff.
The development process, clearly, was not without chal-
lenges. A major challenge was interpreting and incorpo-
rating the local context. Available guidance at the time 
was either high level and generic or was too resource- 
intensive for the context. For example, the guidelines 
from China had CT scans as a diagnostic tool, an unfea-
sible assessment method in our contexts. Within the 
team, there was also a heightened awareness that some 
team members who had experience creating guide-
lines or other clinical expertise, did not have contextual 
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‘I cannot achieve this without input from different team members. I think my role was much overarching the 
project, for example, I think one of the roles is that I need to identify the different areas we have to work, and 
then to add the people who can work in this area.’
‘Looking back, it was a hard time for anyone to be writing guidelines…I reached out to [clinical colleague] 
who has a lot of clinical experience, she’s really busy looking after the running all of our health programs…






‘I think there is an amalgamation of work of different projects, so the documents weren’t fully developed, 
and are in the draft form so going back and forth with team members to finalise either the wording or doing 
copy edits of the guidelines themselves…That was the process going back and forth.’
‘When each team member had the guidelines, it was like it was their responsibility, to check and double 
check everything and work together to confirm the contents. There was hesitation by some non- clinical team 
members but ultimately, by each team member from their unique disciplinary perspective and experience 
taking responsibility and flagging issues or asking questions, it created this shared ownership.’
‘I think one of the tricky things about the nature of guidelines is you’re giving advice to doctors and nurses 
and it’s also guidelines in the middle of an international crisis when the evidence is unclear, so I think what 
was hard was as I pass this ‘hot potato’ around, who has the authority to have the final say on this? If I imply 






‘We had connections with the Ministry of Health, pandemic management team, all public health networks 
because [team member] worked for them. We had a whole lot of connections there. That was very useful, 
knowing the system helped us to translate and modify it.’
‘I feel you have to speak to the ground level because the upper national level guideline is different. The 
activity at ground level is different from country to country so you have to take the inputs from the grassroot 
level then adapt it to your structure…It’ll be easier or productive, or else, the documents we make will not be 
practiced in the field.’
‘And I think for a few on the team they really wanted to help and had a lot of skills to offer but there was that 





‘I was looking at the WHO interim guidelines…I was looking at some CDC guidelines as well…It’s a bit 
different when you apply it to a low- income country context, there’s not as many supplies, there’s more 
challenges that you have to think about…A lot of the guidelines were coming from high- income countries 
like the UK or USA. Even though we had local input, I wonder if we are missing guidelines from elsewhere 
because they are harder [for us] to access.’
‘The China guideline said that even if they are negative on PCR, they may still have the disease so do a 
CT scan, which was part of the guidelines for them. That was questioned by Sri Lanka, why we have to do 
that?’
‘The most challenging thing was that I knew little of the local context and local practice of relevant staff. 
What I could do was to organise the [existing] contents based on my previous experience in China and 
developed a first draft for further revision by local partners. During the process, I also added some sections 
suggested by the local partners during regular meetings, (mental health support and corpse disposal) 
and updated sections according to latest national guidelines…We can’t just cut and paste under different 







‘I felt that I was going at a snail’s pace with the transcript because I kept finding things in the documents 
and the documents were pretty large…I wanted to defer to the health experts on the content. Knowing that 
it needs to get into a published form… was probably the biggest challenge I faced at that time.’
‘A large part was taking a huge amount of information…and diluting it down, making it readable and 
digestible and also creating desk guides from that as well to make it more digestible. It was big but, a lot 
of it was taking something from larger and abstract and make it more relevant and narrowing it down and 
digestible for people to use on a daily basis.’
‘When you write guidelines, you should be open and honest at that moment, and clearly state that when 
things change, we will update the guidelines.’
‘We went into the process thinking this would be a very positivist exercise, but it’s much more constructivist. 
Things are evolving and emerging – the evidence, the situation on the ground, the virus itself. Developing 
comprehensive guidelines in this situation requires a bit of a mindset shift towards the ‘good enough’ model 
where you get something out that’s good enough given all known information and best clinical practices and 
are clear with each other and with your end users that it will be updated pending new evidence.’
Continued
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expertise, and that some team members with contextual 
expertise, did not feel confident or that it was appro-
priate for them to provide clinical insights. These chal-
lenges required the team to have multiple discussions 
and ongoing meetings to triangulate evidence, experi-
ence, and clinical expertise. Given that the pandemic was 
rapidly unfolding this led to tension between the ideal 
guidelines vs timeliness and usability. This was partic-
ularly the case in the Philippines where health worker 
trainings were conducted nearly immediately after the 
guidelines were printed. A ‘good enough’ approach 
based on best available evidence and practices was taken 
overall, together with transparency that there would be 
updates and iterations as new evidence became available. 
This approach emphasises the importance of getting the 
right information out to front- line workers and staff who 
need it most, as opposed to waiting to create the ‘ideal’ 
guidelines, an abstract goal at odds with the immediate 
needs of health workers. Updating and adapting the 
guidelines with evolving information was a challenge 
given the vast amounts of new knowledge generated in 
early 2020 on the management of COVID-19. Further, the 
guidelines process was challenged by the impact of the 
pandemic, which necessitated rapid development and 
implementation in situations that were at times rapidly 
deteriorating. Additionally, the researchers themselves 
faced pandemic- related challenges including health, 
mental well- being, and increased caregiving and profes-
sional responsibilities. These factors, while challenging, 
were also opportunities for greater team cohesion and 
personal connection around shared struggles. This ulti-
mately strengthened our approach and solutions to chal-
lenges faced in creating the guidelines during the early 
stages of the pandemic.
DISCUSSION
The global emergence of COVID-19 in early 2020 
demanded rapid, easily usable, and context- specific clin-
ical guidelines to ensure the safety of health workers 
and patients. In this autoethnographic study, we have 
elaborated on our process of developing context- specific 
and role- specific guidelines and reflected as a team on 
barriers and enablers to illustrate key lessons learnt 
during this process. We now offer a synthesis of our 
process and lessons learnt in the form of the ‘SPRINT’ 
principles, a novel framework for teams aiming to 
create guidelines in response to public health emergen-
cies caused by emerging infectious diseases (figure 3). 
SPRINT stands for 1) Situational awareness; 2) Prioritisa-
tion and balance; 3) Responsive and reflective; 4) Inter-
disciplinary; 5) Navigating shared responsibilities; and 6) 
Transparency. While these lessons were synthesised from 
experiences in LMICs, the principles are applicable and 
important in all resource- constrained settings responding 
to an epidemic.
First, we emphasise the importance of situational 





‘The frequently updated local national guidelines made the guideline development process more 
complicated as one minor update might influence several sections.’
‘We had already printed [the guidelines] and then there are changes…I guess that the fluidity [to update the 
guidelines] was kind of lost. I like a real- time sense of where we were in training vs updating the guideline. 
And which is also understandable with things coming out at different times so, I don't see that as a fault. But 
content evolving, I think that was [a challenge]. Just getting it in before the next training, needing to know 
[any changes].’
The impact of 
the pandemic
‘In a pandemic, our ability to push forward the work is really hindered by the emergencies. There have been 
a number of emergencies in Philippines and Sri Lanka which has delayed our project. So I don’t think that 
we can specifically prepare something for that.’
‘It felt like there were limited staff and a lot of volatility during the initial phase… there were all of these 
intense situations happening that were underlying the process…so it was good that we had a bigger team, 
the intensity of the situation made us work together well and support each other better and have a lot of 
conversations’
Table 1 Continued
Figure 3 Lessons learnt from the development of 
COVID-19 guidelines.
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situation, current guidelines being used, as well as the 
contexts where guidelines will be applied, with special 
attention to non- clinical settings that may require guid-
ance. In the Philippines, this process resulted in the 
identification of several settings where guidelines for 
community health services were needed but didn’t exist. 
We identified that NGO health workers were under-
served but would require guidelines and training to 
protect themselves and mitigate the spread of COVID-19 
in communities. In Sri Lanka, we received inputs while 
seeking ethical approval for the project, that it must 
include guidelines for ancillary staff such as cleaners in 
health facilities. As such, teams should work closely with 
front line and other health system stakeholders. Early 
on the team should prioritise and balance competing 
demands to set goals for the area of care the guide-
lines will address at an early stage. This should inform 
research such as literature searching, and the develop-
ment priorities.
Throughout the process, teams should be prepared to 
be responsive and reflective to an evolving situation with 
continuous inputs of new evidence and best practices that 
at times may contradict previous evidence. Teams should 
also be prepared to negotiate new power dynamics or 
reimagine existing clinical or research hierarchies to 
ensure that the team is able to be responsive to a changing 
landscape and not internally uphold structures that 
hinder reflection and development. Particularly during 
the development phase, it requires an interdisciplinary 
team to take a ‘good enough’ approach in line with 
best available evidence and prevailing clinical practice. 
Importantly, teams should comprise local staff who know 
the setting, clinical and epidemiological experts, and a 
literature reviewer who passes information to the team. 
Other important skillsets include the behavioural and 
social sciences, design skills, and project management. 
There is a need for ownership and teams should foster 
a culture of navigating shared responsibility, where each 
team member takes ownership of the guidelines when 
it is their turn to review. This should be supported by 
flexible leadership and a focal point person tasked with 
disseminating emerging evidence to the team. Finally, 
teams should make efforts to transparently document the 
evidence informing guideline creation with full acknowl-
edgement that the information will likely be updated as 
new information or best practices emerge.
During public health emergencies, particularly those 
caused by a novel infectious disease, clinical guidelines 
must be developed rapidly while minimising any loss of 
rigour and utility. This contrasts with developing clinical 
guidelines under routine circumstances, where time is 
afforded to draw on and systematically review an ample 
evidence base.21 Indeed, during a public health emer-
gency, guidelines are often initially selected based on a 
familiar model of care, drawing on plans for influenza, 
or for Severe Acute Respiratory Syndrome or Middle 
Eastern respiratory syndrome events. While other coun-
tries, particularly LMICs, based their approaches and 
recommendations on past experiences with cholera or 
Ebola. However, as information emerges on routes of 
transmission and disease characteristics, new disease- 
specific guidance must be developed, typically the remit 
of the WHO or National CDC. However, these guidelines 
are then synthesised and adapted, making them context 
and role specific as per the country’s health system.
Using a collaborative autoethnographic method, our 
study provides an important description and critical 
reflection on the guideline development process by a 
multinational and multidisciplinary team. An important 
limitation of this work is that we were unable to include 
the needs and experiences of community members in 
developing IPC guidelines. Teams embarking on this work 
should actively pursue avenues for community involve-
ment in design processes. Further expansion on this work 
could use the SPRINT principles as complementary to 
codesign frameworks and approaches for patient involve-
ment such as experience- based codesign or others, in the 
context of IPC guideline creation for emerging infec-
tious hazards.22 Another limitation to deep and inclusive 
codevelopment grounded in the research setting is that 
many researchers in our team were based at institutions 
in high income countries. This could potentially skew 
the overarching narrative we present to uphold domi-
nant (eg, Western or high- income country) discourses. 
While the SPRINT principles are key considerations for 
teams undertaking similar work, we also underscore that 
these principles must be grounded in a codevelopment 
approach. Our team understood codevelopment to be 
an iterative process of shared ownership that sought to 
create guidelines with partners, rather than for partners. 
The strength of this approach became apparent when 
our team was able to adapt the guidelines based on feed-
back. This included creating guidelines for at- risk roles 
identified by partners as underserved by current guide-
lines in each context, such as front- line NGO community 
workers in the Philippines or ancillary hospital staff in 
Sri Lanka.
CONCLUSIONS
Guideline development during a pandemic requires a 
robust and time sensitive paradigm. The SPRINT prin-
ciples are particularly useful for adapting guidelines to 
LMICs and other settings using an approach grounded in 
situational awareness, prioritisation and balance, which 
are responsive to change, created by an interdisciplinary 
team navigating shared responsibility and transparency. 
We emphasise that these principles must be grounded in 
codesign and add value to existing national responses. 
In this study, we outline a process and principles, which 
provide a foundation for ongoing collaboration during 
the COVID-19 pandemic. Sharing this process and these 
principles is important given emerging evidence on 
the management of COVID-19, the threat of variants of 
concern, and ongoing vaccination efforts, which also rely 
on IPC guidance.
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Looking ahead to future emerging infectious threats, 
we must collectively act to prevent outbreaks from 
becoming pandemics.23 The SPRINT principles provide 
a blueprint for rapid creation of guidelines to safeguard 
health workers and communities as part of pandemic 
and emergency preparedness and response.
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